Abstract Body

HIV eradication will likely require identification of host factors that govern HIV latency in vivo. We performed global transcriptomic profiling of CD4+ T cells from HIV-infected, ART-suppressed individuals to identify host determinants of HIV persistence.

We measured levels of cell-associated (CA) HIV RNA, and total pol and 2-LTR circle HIV DNA in CD4+ T cells from 69 HIV-infected individuals on suppressive ART for 1-2 years; 23 subjects initiated ART <6 months post-infection (‘Early Tx’), and 46 subjects initiated >1 year post-infection (‘Chronic Tx’). Residual plasma HIV RNA levels were measured using an ultrasensitive, real-time transcription-mediated amplification-based assay, and circulating anti-HIV-1 antibodies were characterized using a limiting antigen assay. We performed flow cytometry and RNA-seq to characterize the immunophenotype and global transcriptome of isolated CD4+ T cells, respectively. False discovery rate (FDR) was used to correct for multiple comparisons in statistical analyses.

Low-level viremia was detected in 19 out of 23 Early Tx (0.5±0.37, mean log copy number ±SD) and 34 out of 46 Chronic Tx individuals (0.46±0.3); detectable frequencies and levels were similar between the two groups. Residual viremia was correlated with expression of the host transcriptional mediator ZBTB1 (Zinc finger and BTB domain containing 1) (FDR<0.005). Levels of CA HIV RNA were correlated with multiple factors belonging to the AP-1 (activator protein-1) transcription factor complex (FDR <0.05). The quantity and avidity of anti-HIV antibodies were higher in the Chronic Tx group as compared to Early Tx (p<0.0001). 71 genes were differentially expressed between the Early Tx and Chronic Tx groups (FDR <0.05), including several genes associated with mitochondrial dysfunction, oxidative phosphorylation, and the histone h3, IL12, T-cell receptor, p38 mitogen-activated protein kinase, and PI3K-Akt complex families.

Residual viremia was readily detectable in the majority of ART-suppressed individuals. The level of viremia was similar in those treated during early versus chronic infection, despite lower levels of immune activation and CA HIV RNA and DNA in those treated early. Several pathways were differentially expressed in the Early Tx group and may contribute to the smaller reservoir size observed in the setting of early ART. Our transcriptomic signatures reveal host factors and pathways that may be targeted to develop curative strategies for HIV infection.